期刊文献+

皮质下血管性认知功能障碍患者血清sCD40L水平的变化 被引量:3

Clinical significance of soluble CD40 ligand in patients with subcortical ischemic cognitive impairment
下载PDF
导出
摘要 目的探讨皮质下缺血性脑血管病(SIVD)认知障碍患者血清中可溶性CD40配体(sCD40L)的水平及其与认知障碍、白质病变(WML)的相关性。方法对SIVD中19例血管性痴呆(VD)患者2、0例血管性无痴呆型认知损害(VCIND)患者及15例年龄及性别相当的健康老年人行认知功能测试,采用酶联免疫吸附法(ELISA)检测受试者血清sCD40L水平;同时行头颅MRI扫描,应用年龄相关白质改变分级方法,对WML评分,进一步分析sCD40L与认知功能、WML的关系。结果①SIVD两组与正常对照组相比,血清sCD40L浓度增高(P<0.05),两组之间差异不显著(P>0.05)。②SIVD患者sCD40L水平与MMSE、MoCA、WML评分均无明显相关性(P>0.05)。结论①皮质下血管性认知障碍患者血清sCD40L水平较正常老年人均明显升高s,CD40L可能参与SIVD发生、发展;②血清sCD40L水平与认知功能损害、白质病变程度无明显相关。 Objective To evaluate the level of soluble CD40 ligand(sCD40L) in the serum of patients with subcortical ischemic vascular disease(SIVD)and the correlation with cognition and white matter lesions(WML).Methods 19 patients with VD,20 patients with VCIND and 15 gender and age matched normal controls(NC) were recruited.All subjects were underwent neuropsychological assessment and conventional MRI.The serum level of sCD40L was detected by enzyme linked immunosorbent assay(ELISA) in all subjects.In addition,the relationship was described among sCD40L,WML and cognitive impairment in patients with SIVD.Results(1) A statistically increase of sCD40L serum level of SIVD patients versus healthy controls was detected(P〈0.05).No significant difference between VD and VCIND groups was observed(P〈0.05).(2) There was no statistically correlation between the serum level of sCD40L and MMSE,MoCA,WML scores(P〈0.05).Conclusions(1) Increased serum level of sCD40L in patients with SIVD might indicate that inflammatory processes may be activated in SIVD.(2) Enhanced serum level of sCD40L could not imply the association with the severity of cognitive impairment and WML in SIVD patients.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第23期4512-4514,共3页 Chinese Journal of Gerontology
基金 河北省自然科学基金资助项目(C2009001483) 国家人力资源与社会保障部留学回国人员择优资助项目(人社部2009-11-6) 河北省2010年医学适用技术跟踪项目(No.GL2010-2)
关键词 皮质下缺血性脑血管病(SIVD) 血管性认知功能障碍 白质病变 可溶性CD40配体 Subcortical ischemic vascular disease Vascular cognitive impairment White matter lesions Soluble CD40 ligand
  • 相关文献

参考文献17

  • 1Erkinjuntti T,Inzitari D,Panton I,et al. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subeortieal vas- cular dementia a solution[ J] ? Ann NY Aead Sci,2000;903:262-72.
  • 2血管性认知功能损害的专家共识[J].中华内科杂志,2007,46(12):1052-1055. 被引量:261
  • 3Roman GC, Tetemichi TK, Erkinjuntti T, et al. Vascular dementia: diag- nostic criteria for research studies. Report of the NINDS-AIREN Interna- tional Workshop [ J ]. Neurology, 1993 ;43 (2) :250-60.
  • 4Wentzel C, Darvesh S, Macknight C, et al. Inter-rater reliability of the di- agnosis of vascular cognitive impairment at a memory clinic [ J]. Neuro- epidemiology,2000 ; 19 (4) : 186 -93.
  • 5张明园,瞿光亚.几种痴呆测试工具的比较[J].中华神经精神科杂志,1991,24(4):194-196. 被引量:89
  • 6Roman GC, Sachdev P, Royall DR, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vas- cular dementia [J]. J Neurol Sci,2004 ; 226 ( 1-2 ) : 81-7.
  • 7Wahlund LO, Barkhof F, Fazekas F,et al. A new rating scale for age-relat- ed white matter changes applicable to MRI and CT [J]. Stroke, 2001 ;32 (6) :1318-22.
  • 8Schonbeck U, Libby P. The CD40/CD40L receptor/ligand dyad [ J]. Cell Mol Life Sci,2001 ;58( 1 ) :443.
  • 9Andre P,Prasad KS,Denis CV,et al. CD40L stabilizes arterial thrombi by a beta 3 integrin-dependent mechansm[ J]. Nat Med ,2002 ;8 (3) :247-52.
  • 10Giunta B, Figueroa KP,Town T, et al. Soluble CD40 ligand in dementia [ JJ. Drugs Future,2009 ;34(4) :333-40.

二级参考文献30

  • 1团体著者,上海精神医学,1990年,增2期,51页
  • 2张明园,中华医学杂志,1990年,70卷,424页
  • 3Hachinski V, ladecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke, 2006,37:2220-2241.
  • 4Chui HC, Nielsen-Brown N. Vascular cognitive impairment. Continuum Lifelong Learning Neurol, 2007,13 : 109-143.
  • 5Chui HC. Vascular cognitive impairment: Today and tomorrow. Alzheimer's and Dementia,2006,2 : 185-194.
  • 6Bowler JV, Gorelick PB. Advances in vascular cognitive impairment 2006. Stroke,2007,38:241-244.
  • 7O'Brien JT. Vascular cognitive impairment. Am J Geriatr Psychiatry, 2006,14:724-733.
  • 8Seines OA, Vinters HV. Vascular cognitive impairment. Nat Clin Pract Neurol, 2006,2:538-547.
  • 9Erkinjuntti T. Subcortical vascular dementia. Cerebrovasc Dis, 2002,13 Suppl 2:58-60.
  • 10Mackowiak-Cordoliani MA, Bombois S, Memin A, et al. Poststroke dementia in the elderly. Drugs Aging, 2005,22:483- 493.

共引文献345

同被引文献54

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部